MK-677 (Ibutamoren): The Complete Guide

MK-677, also called Ibutamoren, is an orally active drug that tells your body to release more of its own growth hormone. It is not a steroid, not a SARM, and despite how often it is grouped with them, it is not technically a peptide either. It is a small molecule that mimics ghrelin, the "hunger hormone," to switch on natural growth-hormone release. People take it hoping for more muscle, better sleep, faster recovery, and anti-aging effects.

This guide is the high-level map of the whole compound: what MK-677 actually is, how it works, what it has been studied for, the doses used in real trials, the side effects, what results the science (not the marketing) actually shows, and where it stands legally. Where a topic deserves its own deep-dive, such as a full dosing chart or a side-by-side comparison with peptides, we keep it short here and point you to a dedicated guide, and you can see where MK-677 ranks among the best peptides for muscle growth. The goal is an honest orientation before you go any deeper.

Key Takeaways

• MK-677 is an oral growth-hormone secretagogue, a small non-peptide molecule that activates the ghrelin receptor to raise your own growth hormone (GH) and IGF-1. It is not a peptide, not a SARM, and not a steroid.
• It is investigational and not FDA-approved for any human use. It is sold "for research use only" and is banned in competitive sport (WADA, year-round).
• The dose studied most in human trials is 25 mg once daily by mouth; the community commonly uses 10-25 mg/day. These are figures reported in trials, not a recommendation.
• What the evidence shows: MK-677 reliably raises IGF-1 (about +60% at 6 weeks, +73% at 12 months in one trial) and modestly increased fat-free mass (~1.1 kg over a year), but did not improve strength and worsened insulin sensitivity / blood sugar.
• Common side effects are increased appetite, water retention, tingling/numbness, and tiredness; a heart-failure trial in frail elderly patients was stopped early over a safety signal.
• Most "gains" are not permanent. GH and IGF-1 return toward baseline after stopping, and water weight is lost.
• For specifics, see the dedicated MK-677 dosing guide, MK-677 side effects deep-dive, and MK-677 vs peptides comparison. New to the topic? Start with what are peptides and how peptides work.

What is MK-677 (Ibutamoren)?

MK-677 is an orally active growth-hormone secretagogue: a lab-made molecule that makes your body release more of its own growth hormone. It does not contain growth hormone and is not injected like one. Instead, you swallow it, and it signals the brain and pituitary to produce a natural GH pulse.

The compound was originally developed by Merck and is now associated with Lumos Pharma, which has studied it under names like OraGrowtH for growth-hormone deficiency (Wikipedia, "Ibutamoren", retrieved 2026-06-15). Chemically it is a "potent, long-acting, orally-active, selective, non-peptide agonist of the ghrelin receptor" (CAS number 159634-47-6; PubChem CID 9939050). That mouthful matters for one practical reason: because it is a small molecule and not a peptide, it survives digestion and works as a pill, while most growth-hormone-related peptides have to be injected.

A point of constant confusion online: MK-677 is frequently lumped in with SARMs (selective androgen receptor modulators) and sold on the same sites, but it is not a SARM. SARMs act on the androgen (testosterone) receptor; MK-677 acts on the ghrelin/GH-secretagogue receptor and has nothing to do with androgens. It is also not a peptide, even though it is sold in the "peptide" market. If those categories are new to you, our what are peptides guide lays out the differences.

Citation capsule. MK-677 (Ibutamoren) is an orally active, non-peptide ghrelin-receptor agonist that acts as a growth-hormone secretagogue. It was developed by Merck and is investigational (not FDA-approved). CAS 159634-47-6; PubChem CID 9939050. Source: Wikipedia, "Ibutamoren," 2026.

How does MK-677 work?

MK-677 works by imitating ghrelin, the body's "hunger hormone," to switch on natural growth-hormone release. It binds the growth-hormone secretagogue receptor (GHSR) in the brain and pituitary, which triggers a pulse of GH; that GH then tells the liver to produce IGF-1 (insulin-like growth factor 1), the messenger behind most of GH's downstream effects.

A detail worth getting right is what MK-677 is chemically, because it changes how it works. It is a non-peptide small molecule, not a peptide hormone. Peptides are short chains of amino acids that the gut largely digests, which is why peptide GH secretagogues such as ipamorelin or sermorelin have to be injected. MK-677 was engineered specifically to dodge that problem: it is a "potent, long-acting, orally-active, selective, non-peptide agonist of the ghrelin receptor," so it survives the stomach and acts as a once-daily pill. That single design choice, a non-peptide secretagogue rather than a peptide, is the whole reason MK-677 is the oral option in a category that is otherwise needles only.

The important design feature is that MK-677 amplifies your own pulsatile GH rhythm rather than flooding the body with a constant outside supply, the way injected synthetic GH does. Your pituitary normally releases GH in bursts (pulses), mostly overnight; MK-677 makes those existing pulses bigger rather than adding a flat, artificial level on top. In the foundational pharmacology trial, 25 mg/day of oral MK-677 in healthy elderly adults raised the mean 24-hour GH concentration by about 97% and lifted IGF-1 from a baseline of roughly 141 to 265 micrograms per liter within four weeks, into the range normally seen in healthy young adults, while preserving the natural pulse pattern rather than abolishing it (Chapman et al., Journal of Clinical Endocrinology & Metabolism, 1996, retrieved 2026-06-15). That GH then tells the liver to make more IGF-1, which carries out most of the downstream effects. Because MK-677 also mimics ghrelin, it drives the most famous side effect along the way: a sharp increase in appetite.

Two pharmacology facts shape how it is used. First, MK-677 has a long functional duration: a single oral dose keeps IGF-1 elevated for roughly 24 hours, which is why once-daily dosing is standard (Wikipedia, "Ibutamoren", retrieved 2026-06-15). Second, at typical doses it raises GH and IGF-1 with relatively little effect on cortisol and prolactin, which historically made it attractive as a research GH secretagogue: an ideal secretagogue lifts GH without dragging up stress hormones, and MK-677 is comparatively clean on that front, one reason it edged out earlier candidate molecules in development. This selectivity is also why it amplifies the overnight pulse so well: it works with the hypothalamic-pituitary rhythm instead of overriding it. For the deeper receptor-and-signaling biology of GH secretagogues in general, see our how peptides work explainer.

The cascade is easiest to see as a chain:

What is MK-677 used for?

MK-677 has no approved medical use; in research it has been studied for muscle wasting, aging, and growth-hormone deficiency, and in the community it is used off-label for muscle, recovery, sleep, and anti-aging. It is important to separate what has been studied from what is claimed.

On the research side, MK-677 has been tested as a potential treatment for sarcopenia and frailty in older adults, for catabolic states and muscle wasting, for growth-hormone deficiency (the current Lumos Pharma development direction), and even, unsuccessfully, for slowing Alzheimer's disease (Sevigny et al., Neurology, 2008, retrieved 2026-06-15). None of these have produced an approved product to date.

On the community side, people use MK-677 hoping for: increased lean muscle and "fullness," faster recovery between training sessions, deeper sleep, improved skin and hair, better bone density, and general anti-aging effects tied to higher IGF-1. The honest framing is that some of these (IGF-1 elevation, modest lean-mass change, deeper sleep) have real research support, while many of the bigger physique and anti-aging claims are extrapolated from mechanism and anecdote rather than proven outcomes. We unpack what is realistic in the results section below.

The main reasons people choose MK-677 over alternatives:

• It is oral. No injections, unlike GH or most GH-related peptides such as ipamorelin and sermorelin.
• It is once-daily. The ~24-hour duration suits a simple bedtime routine.
• It raises your own GH. It works with the body's pulsatile rhythm rather than replacing it.
• It is easy to obtain in the grey market, though legality and quality are real concerns (see below).

What dose of MK-677 has been studied? (overview)

The dose used most often in human trials is 25 mg once daily by mouth, and the community most commonly reports 10-25 mg/day, usually taken at night. These are figures reported in studies and community practice, shared for context, not a dosing recommendation or protocol.

The 25 mg/day figure is the best-anchored number in the literature: it is the dose used in the year-long body-composition trial in healthy older adults (Nass et al., Annals of Internal Medicine, 2008, retrieved 2026-06-15) and in the 12-month Alzheimer's trial of 563 patients (Sevigny et al., Neurology, 2008, retrieved 2026-06-15). Lower doses (10-12.5 mg) appear in community use, often to reduce appetite and water-retention side effects.

Here is a high-level reference of what shows up in trials and reported use. This is an overview only; the full breakdown of timing, titration, and cycling lives in the dedicated MK-677 dosing guide.

Why we keep dosing high-level here. Detailed protocols, titration, and "on/off cycling" are off-intent for a hub overview and would overlap our dedicated dosing article. We give you the trial-anchored numbers and send you to the MK-677 dosing guide for the rest. No invented numbers, ever.

What results can you realistically expect from MK-677?

The most reliable, proven effect of MK-677 is a large, sustained rise in IGF-1; the body-composition effect is real but modest, and it did not improve strength. This is the gap between marketing and evidence, and it is the most useful thing on this page.

The biological effect on the GH/IGF-1 axis is the part the science is most certain about, and it is large. In the foundational dose-finding trial, 25 mg/day raised the average 24-hour GH concentration by about 97% and pushed IGF-1 into the young-adult range within four weeks (Chapman et al., Journal of Clinical Endocrinology & Metabolism, 1996, retrieved 2026-06-15). Later trials confirmed the same IGF-1 response holds up over months. In the landmark two-year randomized trial of 65 healthy older adults (ages 60-81), 25 mg/day of MK-677 raised serum IGF-1 by about 84% versus 17% on placebo, and increased fat-free (lean) mass by roughly 1.1 kg, while the placebo group lost about 0.5 kg. Critically, that lean-mass gain did not translate into better strength or function, and the drug worsened insulin sensitivity and raised blood sugar (Nass et al., Annals of Internal Medicine, 2008, retrieved 2026-06-15). In the Alzheimer's trial, 25 mg/day increased IGF-1 by 60.1% at 6 weeks and 72.9% at 12 months, confirming the compound reliably hits its biological target even though it failed to slow the disease (Sevigny et al., Neurology, 2008, retrieved 2026-06-15). Across three independent trials, then, the GH and IGF-1 increase is the one effect that reproduces every time; the physique and performance payoff is the part that underdelivers.

A few realistic expectations follow from the data:

1. IGF-1 will rise substantially and stays elevated while you dose, then returns to baseline after stopping.
2. Lean mass may increase modestly, but the trial gain was about 1 kg over a year and did not improve measured strength.
3. A lot of early "weight"is water. Fluid retention is common and is lost when you stop.
4. Sleep may deepen. Some research reports increases in slow-wave (deep) and REM sleep, a frequently cited subjective benefit.
5. Gains are largely not permanent. Because the effect depends on continued GH/IGF-1 elevation, most changes reverse after discontinuation.

What are the side effects of MK-677? (overview)

The most common side effects are increased appetite, fluid retention and swelling, tingling or numbness in the hands, fatigue, and worsened blood sugar; a heart-failure trial in frail elderly patients was stopped early over a safety concern. This is a high-level summary; the mechanisms, management, and edge cases are covered in the MK-677 side effects deep-dive.

Because MK-677 mimics ghrelin, a sharp rise in hunger is nearly universal. The GH/IGF-1 elevation drives sodium and water retention, which shows up as puffiness, mild swelling (edema), and several pounds of "water weight." Many users also report carpal-tunnel-like tingling or numbness, joint aches, lethargy, and vivid dreams. The metabolic effects are the most serious for everyday use: trials showed MK-677 can raise fasting blood glucose and reduce insulin sensitivity, a real concern for anyone with prediabetes or diabetes risk (Nass et al., Annals of Internal Medicine, 2008, retrieved 2026-06-15).

The single most-cited safety flag: clinicians note that researchers stopped at least one clinical trial of MK-677 early because of concerns that it might cause heart failure (Healthy Male (Andrology Australia), "MK-677 (Ibutamoren)", 2024, retrieved 2026-06-15). Long-term safety in healthy people is simply not established.

Is MK-677 safe?

No one can honestly call MK-677 "safe": its short-term side effects are well documented, its long-term safety in healthy people is unstudied, and at least one trial was stopped early over a heart-failure concern. It reliably does what it is designed to do biologically, but "it works" is not the same as "it is safe."

The clearest documented risks are metabolic. By raising GH, MK-677 raises blood sugar and reduces insulin sensitivity, which is why it is a poor fit for anyone with diabetes, prediabetes, or strong family risk (Nass et al., Annals of Internal Medicine, 2008, retrieved 2026-06-15). On top of that, chronically elevated IGF-1 is a theoretical long-term concern, because IGF-1 is itself a growth signal.

The cardiovascular question is the one that most affected the compound's development. According to clinical guidance, researchers stopped at least one MK-677 trial early specifically because of a concern that the drug might cause heart failure (Healthy Male, 2024, retrieved 2026-06-15). The most plausible mechanism is the same fluid retention that produces the visible "water weight" side effect: GH and IGF-1 drive the body to hold onto sodium and fluid, which raises circulating volume, and in a heart that is already weak, extra fluid load can tip toward congestive heart failure. Trial dosing was once daily for months, so this was not a high-dose anomaly. It is the clearest example of why "it works" and "it is safe" are different questions: the cardiovascular picture for long-term use in healthy people is genuinely unresolved, not reassuring.

There is also a quality dimension specific to a research-chemical market: what you buy may not be pure MK-677, may be underdosed or contaminated, and is not made to pharmaceutical standards. That is a separate risk layer on top of the compound itself, and it is why third-party testing matters. See how to vet peptide quality for what a real certificate of analysis looks like.

Our take: MK-677 is one of the better-studied research compounds in this space, which cuts both ways. The studies confirm it raises IGF-1 and lean mass, and they are exactly why we know it worsens blood sugar and carries an unresolved cardiac question. "Better studied" does not mean "shown to be safe."

Is MK-677 legal?

MK-677 is not approved by the FDA for human use and is sold only as a "research chemical," not as a supplement or medicine; it is also banned in competitive sport year-round. Its exact legal status depends on your country and on how it is sold and used.

In the United States, MK-677 is an investigational drug that has never been approved for marketing for human consumption (Wikipedia, "Ibutamoren", retrieved 2026-06-15). It is not a legal dietary supplement; selling it as one is unlawful, which is why vendors label it "for research use only." In other countries it can be more tightly controlled: Australia, for example, has no approved use for the drug and treats it as an experimental substance (Healthy Male, 2024, retrieved 2026-06-15).

For athletes, the line is simple: MK-677 is on the World Anti-Doping Agency (WADA) Prohibited List as a growth-hormone secretagogue and is banned at all times, in and out of competition. Specifically, ibutamoren is listed under category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), section S2.2.4, growth hormone secretagogues, which is prohibited at all times rather than only on competition day (Sport Integrity Australia, "Ibutamoren (MK-677) Information", 2026, retrieved 2026-06-15). In practice that means it can trigger an anti-doping violation whether an athlete is in or out of season, and it is detectable on a doping test. The broader rules and grey-market realities are covered in our dedicated are peptides legal guide.

How do people obtain MK-677? (high-level)

Because it is not an approved product, MK-677 is bought almost entirely through "research chemical" vendors online, where quality is unregulated and varies widely. We cover this at a high level only and do not endorse or instruct on purchasing.

The practical reality is a grey market: there is no pharmacy supply for human use, so products come from research-chemical sellers as capsules, tablets, or liquid solutions. The dominant buyer concern is authenticity, because there is no regulator checking purity, dose accuracy, or contamination. The minimum due-diligence signal serious buyers look for is a recent third-party certificate of analysis (COA) with HPLC/mass-spec purity testing tied to the specific batch.

We deliberately keep this short, since vetting vendors is its own skill set. For the full checklist, see how to vet peptide quality and the legal context in are peptides legal.

MK-677 vs peptides and other GH options (mini-overview)

MK-677's main selling point versus GH-related peptides is that it is oral and once-daily, while peptides like ipamorelin, CJC-1295, and sermorelin require injections. This is a quick orientation; the full side-by-side lives in our MK-677 vs peptides comparison.

The key contrasts at a glance: MK-677 is a non-peptide small molecule taken by mouth with a ~24-hour duration, so one daily dose holds IGF-1 up. The injectable GH secretagogue peptides (ipamorelin, CJC-1295, sermorelin) are peptides given subcutaneously, often more than once a day, and they tend to cause less appetite and water retention than MK-677; our ipamorelin vs MK-677 head-to-head digs into that oral-versus-injectable trade-off directly. Synthetic HGH itself is a different category again: far more potent, injection-only, expensive, and a controlled prescription drug.

We keep this deliberately shallow to avoid duplicating the dedicated comparison. Use it to decide whether MK-677's oral convenience is worth its side-effect profile for your situation, then read the full comparison.

How ProtocolPlus users track MK-677

Among ProtocolPlus trackers, MK-677 is the most-tracked oral compound, logged by about 1,472 users across roughly 9,200 logged doses, reflecting its appeal as a no-needle option. These figures are shown server-side so they are crawlable, and they trace to our canonical userbase dataset.

Because MK-677 is oral, the tracking pattern differs from injectables: there are no vial-reconstitution or "days-to-empty" stats, just daily oral logs. The community typical dose recorded sits in the 10-25 mg/day range, matching the trial-anchored figures above.

Frequently Asked Questions

The bottom line

MK-677 (Ibutamoren) is an oral, once-daily growth-hormone secretagogue that does one thing very reliably: it raises your own growth hormone and IGF-1. That mechanism is real and well documented, which is exactly why we also know its limits. In the best human trial it added only about a kilogram of lean mass over a year, did not improve strength, and worsened blood sugar, and a separate trial was halted early over a heart-failure concern. It is investigational, not FDA-approved, sold as a research chemical, and banned in sport.

If you take one thing from this guide, make it this: separate "it works" from "it is safe." MK-677 demonstrably works on IGF-1, but it is not proven safe for long-term use in healthy people, and most of its effects fade once you stop. From here, the natural next steps are the detailed MK-677 dosing guide, the side effects deep-dive, and the comparison with peptides. And before considering any research compound, talk to a qualified healthcare professional.

Sources

• Chapman IM, Bach MA, Van Cauter E, et al. "Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects." Journal of Clinical Endocrinology & Metabolism, 1996. Retrieved 2026-06-15. https://pubmed.ncbi.nlm.nih.gov/8954023/
• Nass R, Pezzoli SS, Oliveri MC, et al. "Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial." Annals of Internal Medicine, 2008. Retrieved 2026-06-15. https://www.acpjournals.org/doi/10.7326/0003-4819-149-9-200811040-00003
• Sevigny JJ, Ryan JM, van Dyck CH, et al. "Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial." Neurology, 2008. Retrieved 2026-06-15. https://pubmed.ncbi.nlm.nih.gov/19015485/
• ClinicalTrials.gov. "Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults" (NCT00474279). University of Virginia. Retrieved 2026-06-15. https://clinicaltrials.gov/study/NCT00474279
• Healthy Male (Andrology Australia). "What you need to know about MK-677 (Ibutamoren)." 2024. Retrieved 2026-06-15. https://healthymale.org.au/health-article/what-you-need-to-know-about-mk-677-ibutamoren
• Sport Integrity Australia. "Ibutamoren (MK-677) Information." 2026. Retrieved 2026-06-15. https://www.sportintegrity.gov.au/what-we-do/anti-doping/substance-education/ibutamoren-mk-677-information
• Wikipedia. "Ibutamoren." Retrieved 2026-06-15. https://en.wikipedia.org/wiki/Ibutamoren
• Rupa Health. "MK-677: Your Ultimate Ibutamoren Resource." Retrieved 2026-06-15. https://www.rupahealth.com/post/mk-677-your-ultimate-ibutamoren-resource
• BodyNutrition. "Ibutamoren (MK-677) Clinical Evidence Guide." 2026. Retrieved 2026-06-15. https://bodynutrition.org/ibutamoren/